NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 44 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -72.7% | 22,309 | +28.4% | 0.00% | – |
| Q1 2022 | $33,000 | -57.1% | 17,375 | -36.2% | 0.00% | – |
| Q4 2021 | $77,000 | -24.5% | 27,252 | -3.4% | 0.00% | – |
| Q3 2021 | $102,000 | -87.8% | 28,200 | -83.8% | 0.00% | -100.0% |
| Q2 2021 | $834,000 | +143.9% | 174,020 | +276.2% | 0.00% | – |
| Q1 2021 | $342,000 | +147.8% | 46,253 | +134.8% | 0.00% | – |
| Q4 2020 | $138,000 | -96.3% | 19,697 | -95.3% | 0.00% | -100.0% |
| Q2 2020 | $3,682,000 | +2104.8% | 419,325 | +1689.3% | 0.01% | – |
| Q1 2020 | $167,000 | -18.9% | 23,435 | -18.2% | 0.00% | – |
| Q4 2019 | $206,000 | – | 28,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |